[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"alopecia-drugs\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:alopecia-drugs":31},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":33,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":5},"100537860","systemic-treatments-for-alopecia-areata-registry-100537860",false,"NCT06283316","Systemic Treatments for Alopecia Areata Registry","STA2R","Inclusion Criteria:\n\n* Diagnosed with alopecia areata;\n* Starting\u002Fusing a systemic treatment for alopecia areata;\n* Informed consent for registry participation obtained from patient and\u002For caretaker.\n\nExclusion Criteria:\n\n* Not sufficiently capable of understanding the Dutch language;\n* Not willing to participate.","ALL","16 Years",{"count":19,"type":20},10000,"ESTIMATED","50 Years","OBSERVATIONAL","A multicenter prospective registry (STA2R) is conducted to assess systemic treatments for alopecia areata, focusing on effectiveness, safety, and long-term outcomes.",[25,26,27,28,29,30,31,32],"Alopecia Areata","Alopecia Totalis","Alopecia Universalis","Hair Loss","Hair Diseases","Alopecia","Alopecia Drugs","Autoimmune Diseases",[25,26,27,34,35],"Systemic treatment","Registry","RECRUITING","2024-02-27",{"date":39,"type":40},"2024-02-28","ACTUAL",{"date":42,"type":40},"2024-01-17",{"date":44,"type":20},"2099-12-31",{"name":46,"class":47},"Erasmus Medical Center","OTHER"]